CollPlant Biotechnologies Ltd (CLGN) Operating cash flow 2018–2025
CollPlant Biotechnologies Ltd (CLGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.4MFY2025 · since FY2018: -$1.2M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.4M | +33.2% |
| FY2024 | -$14.1M | -410.1% |
| FY2023 | -$2.8M | +79.8% |
| FY2022 | -$13.7M | -647.7% |
| FY2021 | $2.5M | +156.2% |
| FY2020 | -$4.5M | +22.0% |
| FY2019 | -$5.7M | -368.6% |
| FY2018 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating marginCLGN Free cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →